Summary
Ann Oncol. 2017 Aug 1;28(8):2028-2029. doi: 10.1093/annonc/mdx227.
64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer.
Abstract:
日本語要旨:
PMID:  28505219
Ann Oncol. 2017 Aug 1;28(8):2028-2029. doi: 10.1093/annonc/mdx227.
64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer.
Abstract:
日本語要旨:
PMID:  28505219